Network meta-analysis of the outcome ‘participant complete clearance’ in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review

A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett’s oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin

(2014) D Fayter et al.   HEALTH TECHNOLOGY ASSESSMENT

Photodynamic Therapy of Non-melanoma Skin Cancer with Methyl Aminolaevulinate is Associated with Less Pain than with Aminolaevulinic Acid

(2012) M Gaál et al.   ACTA DERMATO-VENEREOLOGICA

A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: Clinical and histologic outcomes

(2012) Carlos Serra-Guillén et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Ingenol Mebutate Gel for Actinic Keratosis

(2012) Mark Lebwohl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

(2011) T. Dirschka et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment with 5-Aminolaevulinic Acid Methylester Is Less Painful than Treatment with 5-Aminolaevulinic Acid Nanoemulsion in Topical Photodynamic Therapy for Actinic Keratosis

(2011) Patrick Gholam et al.   DERMATOLOGY

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

(2010) R.-M. Szeimies et al.   BRITISH JOURNAL OF DERMATOLOGY

Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses

(2010) Edward C.F. Wilson   PHARMACOECONOMICS

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial

(2009) K. Gebauer et al.   BRITISH JOURNAL OF DERMATOLOGY

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies

(2009) A. Hauschild et al.   BRITISH JOURNAL OF DERMATOLOGY

Topical Methyl Aminolevulinate Photodynamic Therapy Using Red Light-Emitting Diode Light for Multiple Actinic Keratoses

(2009) Rolf-Markus Szeimies et al.   DERMATOLOGIC SURGERY

An economic evaluation of topical treatments for actinic keratosis

(2009) Dominic Muston et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis

(2009) Lawrence Anderson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Topical photodynamic therapy with porphyrin precursors—assessment of treatment-associated pain in a retrospective study

(2009) Julia Maria Steinbauer et al.   PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study

(2008) David Pariser et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY